Thoracic Oncology Program At University Of Maryland Greenebaum Cancer Center
This institutions 200 cancer specialists utilize a multidisciplinary approach, with representation of many cancer specialties including mesothelioma and lung cancer. For this reason, Greenebaum established the Thoracic Oncology Program, a team of physicians, surgeons, radiologists, oncologists, pulmonologists, nurses and social workers skilled and experienced in the treatment of these cancers.
One of the programs specialists is Richard J. Battafarano, M.D., chief of the division of Thoracic Surgery and an expert in mesothelioma and lung and esophageal cancers.
Mesothelioma Clinical Trials At University Of Maryland Greenebaum Cancer Center
- A phase I/II clinical trial studying the safety and efficacy of using neoadjuvant nivolumab and ipilimumab prior to surgery for pleural mesothelioma.
- A phase I/II clinical trial to study the effectiveness of using pembrolizumab with anetumab ravtansine, in contrast to using pembrolizumab alone, for patients with unresectable pleural mesothelioma.
- A phase II clinical trial to measure the effectiveness of using ADI-PEG 20 with standard chemotherapy, in contrast to using chemotherapy with a placebo, for patients with pleural mesothelioma.
Disclaimer: Watch Our Free Mesothelioma Webinars
Select Scientific Initiatives At Umgccc
UMGCCC is a national leader in many areas of cancer research, with comprehensive programs in experimental therapeutics for hormone-related cancers, molecular and structural biology, population science, and tumor immunology and immunotherapy. Cutting-edge research underway at the cancer center includes:
- A first-of-its-kind clinical trial in the United States using focused ultrasound and microbubbles to disrupt the brains protective bloodbrain barrier in order to deliver chemotherapy directly to difficult-to-treat brain tumors.
- Development of new approaches to train a patients own immune system to fight cancer. More than two dozen clinical trials at the center utilize immunotherapy, and UMGCCCs state-of-the-art cell-processing laboratory, the Fannie Angelos Cellular Therapeutics Laboratory, provides in-house support to advance this research.
- Clinical testing of galeterone, a drug developed at UMGCCC that had shown significant clinical activity against advanced prostate cancer. Based on promising preclinical studies, the drug is being tested in a clinical trial as a potential new treatment for pancreatic cancer.
*This profile provided by the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center.
Don’t Miss: Blood Test For Colon Cancer
Groundbreaking For Major Expansion Of University Of Maryland Greenebaum Comprehensive Cancer Center
$219 Million Tower Will Advance Clinical Care and Research to Meet the Growing Needs of Cancer Patients Throughout Maryland and the Region
Rendering of planned Roslyn and Leonard Stoler Center for Advanced Medicine
Newswise BALTIMORE The University of Maryland Medical Center today celebrates the groundbreaking of a nine-story patient care tower the Roslyn and Leonard Stoler Center for Advanced Medicine that will become the new home of the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center .
The $219 million tower will enable UMGCCC to provide the most technologically advanced, integrated care to cancer patients throughout Maryland and the region well into the future. The structure will feature a distinctive metal and glass façade built onto the front of UMMCs existing downtown campus at 22 S. Greene Street, transforming the face of the academic medical center and creating a new main entrance.
Bert W. OMalley, MD, UMMCs President and CEO, who is also a head and neck surgeon at UMGCCC and Professor of Otorhinolaryngology-Head and Neck Surgery at UMSOM, said the new building will help to position the cancer center for the future. We want to expand both our inpatient and outpatient services to meet the increasing demand for highly specialized cancer care, particularly for people diagnosed with complex cancers, he said.
New Urgent Care Center for Cancer Patients
Advances in Cancer Treatment
University Of Maryland Medical Center Hopes New Baltimore Cancer Center Will Advance Treatment Care
What if in the next few years patients with cancer in their lungs or blood could sit in a chair, get an infusion of their own modified cells to wipe out their cancer and go home?
Cancer researchers and doctors around the country are working on it not only replacing rounds of toxic chemotherapy with the most advanced immunotherapies but also making the cutting edge treatments more readily accessible and even comfortable.
A big piece of the effort locally starts coming together Friday when the University of Maryland Medical Center breaks ground on a new $219 million cancer center.
The Roslyn and Leonard Stoler Center for Advanced Medicine will rise in front of the downtown Baltimore hospital and house the Marlene and Stewart Greenebaum Comprehensive Cancer Center. Its slated to open in 2025.
Dr. Kevin Cullen, director of the Greenebaum Cancer Center, said the new center was designed in anticipation of medical advances and patient needs.
Well be able to offer a bone marrow transplant, for example, in an extended-stay environment. You stay for treatment and go home and come back the next day, Cullen said ahead of the groundbreaking. We dont have that capability now.
Cullen said the center already is among the first in the region to offer some immunotherapy treatments that will only expand.
A big and promising front in those treatments focuses on immunotherapies, which train peoples own immune systems to target and kill cancer cells.
Read Also: What Is External Beam Radiation
University Of Maryland Greenebaum Comprehensive Cancer Center
Benefiting the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, The Maryland Half Marathon & 5K has become a mainstay within the state offering something for everyone a challenging half marathon and a 5K for more casual runners. This event brings together the community to run with a purpose’ and has helped to raise more than $2 million since the inaugural event in 2008 in the fight against cancer.
Overview Of Case Study
UMMC is the academic medical center of the 13-hospital University of Maryland Medical System. The initial UMMC structure was built in 1937, and six additions from 1957 to 2013 have brought the facilitys floorspace to 2.5 million square feet.
Richie Stever, CHFM, CLSS-HC, UMMCs director of operations and maintenance, did not have specific outcomes in mind for the treasure hunt. He saw the treasure hunt as a way to help UMMC reach its goal of reducing energy consumption by 20 percent by 2022 as part of the Better Buildings Challenge through the U.S. Department of Energy .
Recommended Reading: Prostate Cancer Side Effects Of Radiation
More About Mesothelioma Treatment At University Of Maryland Medical System
University of Maryland Medical System has a network of hospitals along with a top cancer center. The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center features more than a half dozen mesothelioma specialists.
The medical system includes the Mesothelioma and Thoracic Oncology Treatment and Research Center. A dedicated center and team for mesothelioma is an ally for patients needing top-end cancer care.
University Of Maryland Medical System
22 S. Greene Street, Baltimore, Maryland 21201
University of Maryland Medical System welcomes patients with pleural mesothelioma to the hospital and cancer center. Surgery, chemotherapy and other treatment options are used on a case-by-case basis.
University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
22 S. Greene Street
Read Also: Is Chemo Or Radiation Worse
Trimodal Therapy At University Of Maryland Medical Comprehensive Cancer Center
University of Maryland Medical Systems approach to mesothelioma care is multimodal therapy, meaning multiple options used at different stages of the process. Since the medical system has a top cancer center and the Mesothelioma and Thoracic Oncology Treatment and Research Center, doctors can form an individualized approach for each patient.
Part of the multimodal therapy program for mesothelioma is radiation therapy. University of Maryland Medical System is beginning to incorporate proton radiation therapy, a more precise type of radiation, into the Mesothelioma and Thoracic Oncology Treatment and Research Center. This cancer center is only one of a few in the United States to use proton radiation for mesothelioma.
Research Key At University Of Maryland Greenebaum Cancer Center
Not surprisingly, this hospitals lung cancer research program is among the nations best. The Thoracic Oncology Programs investigators and physicians regularly participate in all aspects of protocol development, design and implementation, including translational research, which quickly and directly transfers laboratory findings to patients. Overall, these physicians and investigators participate in about 150 clinical cancer trials at any given time, resulting in $62 million in research funding.
Among the achievements for lung cancer and associated thoracic diseases are the development of advanced anti-cancer drugs safer, more accurate intensity-modulated radiation therapy and gene therapy programs.
Read Also: Chemo Therapy For Breast Cancer
Best Way To Connect With University Of Maryland Cancer Center
The University of Maryland Cancer Center has provided life-saving treatment for many people suffering from mesothelioma and continues to research new ways to fight the disease. Reasons patients have chosen this cancer hospital for mesothelioma treatment include:
- Access to new clinical trials and studies
- Specialized support and counseling for patients and families
The patient care team at Mesothelioma Guide has an extensive database of the top cancer centers in the United States many of which treat mesothelioma with compassion, thoroughness and attention to detail. Our lead patient advocate and registered nurse, Karen Ritter, is a valuable resource for any patient seeking treatment.
Email Karen at or request her cancer center recommendations through our website. You wont regret relying on Mesothelioma Guides medical staff for help in finding the best treatment possible for your diagnosis.
University Of Maryland Greenebaum Cancer Center Treats Mesothelioma
The programs members regularly meet to evaluate patient profiles and review and discuss new and existing therapies. When it comes to mesothelioma and other asbestos-related diseases, this team is able to utilize this multidisciplinary approach to enable patients to consult with multiple specialties in one setting. This includes radiologic evaluation to diagnose tumor stages and design therapies.
Treatment options, which may depend on specific diagnoses and disease severity, include:
Don’t Miss: Stage 4 Liver Cancer Treatment
The Greenebaums: Our Patrons
In 1996, Baltimore-based real estate developer Stewart Greenebaum and his wife, Marlene, made a $10 million gift to the University of Maryland Medical System and the University of Maryland School of Medicine. The largest private contribution ever made to the School or Hospital, the gift was made in recognition of the Medical Centers “extraordinary growth and progress.”
In recognition of the record-breaking gift, the Medical System and School of Medicine renamed the University of Maryland Cancer Center after the Greenebaums.
About The Writer Karen Ritter Rn Bsn
Karen Ritter, a registered nurse, is the lead patient advocate for Mesothelioma Guide. She has a deep passion for patient care, which includes helping patients and their families search for treatment options at the top mesothelioma cancer centers. She finds the balance between encouraging patients to receive the best treatment possible while enjoying their time with loved ones and friends. Karen is a valuable asset for patients due to her knowledge of mesothelioma, compassion for the victims of this disease and dedication to guiding patients through their treatment journey.
Also Check: Cell Tower Radiation Health Effects
Outpatient Care Locations The Roslyn And Leonard Stoler Pavilion
Outpatient care for most cancer patients at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center is provided in the state-of-the-art Roslyn and Leonard Stoler Pavilion located just inside the main hospital lobby. Stoler Pavilion hours of operation are 8:00 a.m. – 4:30 p.m., Monday through Friday.
If you have a question about your medications, need to change an appointment or have other non-emergency concerns and would like to speak with a nurse or other staff member, please call the Patient Assistance Line at 410-328-7609.
All messages are returned within 24 business hours Monday through Friday, 8:00 a.m. – 4:30 p.m.
University Of Maryland Greenebaum Cancer Center Leads In Research And Care
The University of Maryland Marlene and Stewart Greenebaum Cancer Center is a leading destination for the care and treatment of mesothelioma and lung cancer. This institution was established in 1965 as part of an intramural program formed by the National Cancer Institute , with the goals of developing basic and clinical research for cancer treatment and providing training for medical and basic scientists.
Located on the University of Marylands medical campus, Greenebaum Cancer Center is a component of the Medical Center and the School of Medicine. Therefore, all Greenebaum researchers and physicians are on its faculty. In its history, the cancer center has reaped many prestigious honors, including the NCIs designation as a Comprehensive Cancer Center, meaning it maintains the highest standards of excellence in patient care, clinical research, cancer prevention, education and basic science.
U.S. News & World Report listed the University of Maryland Marlene and Stewart Greenebaum Cancer Center as one of Americas Best Hospitals. Every year 45,000 patients visit the center, many drawn to the hospitals Roslyn and Leonard Stoler Pavilion, a state-of-the-art outpatient center.
You May Like: What Is Papillary Thyroid Cancer
About The Marlene And Stewart Greenebaum Comprehensive Cancer Center
The University of Maryland Comprehensive Cancer Center is one of the top cancer treatment and research centers in the country. In 2016, the National Cancer Institute elevated UMGCCC to its designation as a comprehensive cancer center one of only 50 in the nation. As part of the University of Maryland Medical Center, we offer innovative approaches to diagnosing and treating all types of cancer, conduct cutting-edge research to bring the latest advances in cancer treatment directly to our patients, and provide cancer screening and patient education services.
Get Connected To University Of Maryland
University of Maryland Medical System welcomes mesothelioma patients to its Marlene and Stewart Greenebaum Comprehensive Cancer Center. Patients will work with a team of specialists.
Why Choose University of Maryland?
- Treatment and research center dedicated to mesothelioma
- Personalized treatment plans for patients
Recommended Reading: How Many Days After Chemo Do You Feel Better
Notable Clinical And Research Activities
- UM Professor of pharmacology Angela H. Brodie, Ph.D., pioneered the development of a new class of breast cancer drugs, aromatase inhibitors, now the standard of care for women worldwide.
- UM Radiation oncology physicists developed direct aperture optimization , an IMRT planning technique that dramatically reduces treatment time.
- Research in new drug development and new anti-cancer drugs. Virtually every important drug in use in oncology today has been tested in this program, and the center has contracts in both the public and private sectors with a commitment to clinical and laboratory research.
- Strong translational research program in immunotherapy and biological therapy of cancer and is developing a gene therapy program focused primarily on hematologic malignancies.
- Leader in minority participation in clinical studies. More than 30 percent of participants are minorities, far exceeding the U.S. average of less than 10 percent.
- Partnership with the state of Maryland through the Maryland Cigarette Restitution Fund Program, which provides funds to strengthen research programs, expand clinical trials, and recruit world-class scientists and cancer specialists.
Cancer Center Maintains Highest Level Of Distinction
July 23, 2021 | By
The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center has earned renewal of its National Cancer Institute designation as a Comprehensive Cancer Center for another five years. The prestigious distinction recognizes the cancer centers high caliber of scientific leadership and robust programs in basic, clinical, and population science research, placing it in the top echelon of cancer centers nationwide.
The cancer center a joint entity of the University of Maryland Medical Center and the University of Maryland School of Medicine has been approved to receive a support grant of nearly $13 million from NCI over the next five years, a 14 percent increase over the previous five-year grant award. UMGCCC was named an NCI-designated cancer center in 2008 and was elevated to Comprehensive Cancer Center status NCIs highest designation in 2016.
Kevin J. Cullen, MD
The renewal of our designation is a tremendous achievement for our entire team a process made even more challenging by the COVID-19 pandemic, said Kevin J. Cullen, MD, the Marlene and Stewart Greenebaum Distinguished Professor in Oncology at UMSOM and the cancer centers director. I am very proud of the hard work and dedication of our faculty and staff who embraced our renewal bid while continuing to provide lifesaving care to our patients under extraordinarily difficult circumstances.
Read Also: How Much Are Radiators For Cars
Stoler Center For Advanced Medicine Breaks Ground
May 16, 2022 | By
The University of Maryland Medical Center celebrated the groundbreaking May 13 of a nine-story patient care tower the Roslyn and Leonard Stoler Center for Advanced Medicine that will become the new home of the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center .
The $219 million tower will enable UMGCCC to provide the most technologically advanced, integrated care to cancer patients throughout Maryland and the region well into the future. The structure will feature a distinctive metal and glass façade built onto the front of UMMCs existing downtown campus at 22 S. Greene St., transforming the face of the academic medical center and creating a new main entrance.
Dr. Bert O’Malley, Gov. Larry Hogan, Dr. Kevin Cullen, and Dr. Mohan Suntha pose with a governor’s declaration in honor of the Stoler Center for Advanced Medicine.
Bert W. OMalley, MD, UMMCs president and CEO, who is also a head and neck surgeon at UMGCCC and Professor of Otorhinolaryngology-Head and Neck Surgery at UMSOM, said the new building will help to position the cancer center for the future. We want to expand both our inpatient and outpatient services to meet the increasing demand for highly specialized cancer care, particularly for people diagnosed with complex cancers, he said.
New Urgent Care Center for Cancer Patients
Advances in Cancer Treatment